Cite
HARVARD Citation
Tarhini, A. et al. (2015). Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Journal for immunotherapy of cancer. 3 (1), p. . [Online].